Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
MRI Evaluation of Chest Pain
This study has been completed.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001961
  Purpose

This study will assess the value of magnetic resonance imaging (MRI) in detecting heart attack and heart attack risk in patients who come to the hospital emergency room because of chest pain. It will also investigate whether MRI can help predict the coronary status of patients 4 to 6 weeks and 1 year after emergency room admission.

Patients who come to the emergency room of Suburban Hospital in Bethesda, MD, because of chest pain may be asked to enroll in this study if they have not been diagnosed as having a heart attack. Participating patients will undergo a MRI scan as soon as emergency room doctors determine they are in stable condition. For this procedure, the patient lies on a table that slides into the MRI scanner-a large tubular machine with a magnetic field. During the scan, a contrast material is injected into the vein. This material brightens the image of the heart so that the blood flow can be seen. The scan will show if there are areas of heart muscle that received insufficient blood flow. A second scan will be done within 72 hours to look for coronary artery blockage that may require treatment. Patients will be followed by telephone 4 to 8 weeks after the scans and again 1 year after the scans to ask about any significant medical problems that may have occurred during those time periods.

This study will provide information that may improve emergency treatment of patients with acute chest pain by clarifying which patients require immediate medical treatment, which should be admitted to the hospital for further evaluation, and which may safely be discharged from the hospital.


Condition Intervention Phase
Chest Pain
Coronary Disease
Myocardial Infarction
Procedure: MRI
Phase II

MedlinePlus related topics: Chest Pain Coronary Artery Disease Heart Attack Nuclear Scans
Drug Information available for: Adenosine
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Safety/Efficacy Study
Official Title: MRI Evaluation of Chest Pain Compatible With Myocardial Ischemia

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 360
Study Start Date: December 1999
Estimated Study Completion Date: January 2005
Detailed Description:

Coronary artery disease remains the leading cause of death in the United States and results in high diagnostic and therapeutic costs. The overall costs associated with the care of patients with cardiovascular disease is projected to be $286.5 billion. Although MRI is a relatively expensive technology, this methodology can provide all the noninvasive diagnostic testing necessary to evaluate and triage patients with coronary artery disease. This "one stop shop" has the potential to lower overall testing on this important patient population and better delineate which patients require intervention. Beyond reproducing the results of existing diagnostic tests, MRI has unique abilities to characterize myocardial tissue adding information in the assessment of these patients that is not attainable by currently available methodologies. This study will examine the hypothesis that MRI assessment of regional LV function, resting myocardial perfusion, and myocardial tissue characteristics can accurately detect a higher fraction of patients with acute myocardial infarction than is possible with the ECG performed in the emergency department.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

INCLUSION CRITERIA:

Ages above age 21 (children are excluded because myocardial infarction is so rare in this population that the pre-test probability is comparable to the patients with less than 30 minutes of symptoms. Both of these groups have too small a fraction of true positive events to benefit from testing with a sensitivity and specificity of approximately 0.85. If initial results are better, we will reexamine the suitability of these tests for low risk populations).

Capable of giving informed consent.

30 minutes of chest pain compatible with myocardial ischemia (chest pain score greater than 4).

Less than 270 pounds.

EXCLUSION CRITERIA:

Medical exclusions:

Patient states she may be pregnant (confirmed by urine or blood testing).

Severe congestive heart failure (unable to lie flat in bed).

Subjects on a mechanical ventilator.

MRI exclusions:

Subjects with a cardiac pacemaker or implantable defibrillator.

Subjects with a cerebral aneurysm clip.

Subjects with a neural stimulator (e.g. TENS-Unit).

Subjects with any type of ear implant.

Subjects with metal in eye (e.g. from machining).

Subjects with implanted devices (e.g. insulin pump, drug infusion device).

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001961

Locations
United States, Maryland
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Publications:
Study ID Numbers: 000025, 00-H-0025
Study First Received: January 18, 2000
Last Updated: March 3, 2008
ClinicalTrials.gov Identifier: NCT00001961  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Myocardial Infarction
Coronary Artery Disease
Adenosine
Stress Testing
Perfusion

Study placed in the following topic categories:
Arterial Occlusive Diseases
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Stress
Pain
Ischemia
Arteriosclerosis
Chest Pain
Coronary Disease
Signs and Symptoms
Necrosis
Infarction
Adenosine
Myocardial Infarction
Coronary Artery Disease

Additional relevant MeSH terms:
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009